[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR122020000059B8 - composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit - Google Patents

composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit

Info

Publication number
BR122020000059B8
BR122020000059B8 BR122020000059A BR122020000059A BR122020000059B8 BR 122020000059 B8 BR122020000059 B8 BR 122020000059B8 BR 122020000059 A BR122020000059 A BR 122020000059A BR 122020000059 A BR122020000059 A BR 122020000059A BR 122020000059 B8 BR122020000059 B8 BR 122020000059B8
Authority
BR
Brazil
Prior art keywords
platelet
growth factor
derived growth
kit
biocompatible matrix
Prior art date
Application number
BR122020000059A
Other languages
English (en)
Other versions
BR122020000059B1 (pt
Inventor
K Kestler Hans
A Wisner-Lynch Leslie
E Lynch Samuel
Liu Yanchun
Original Assignee
Biomimetic Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomimetic Therapeutics Inc filed Critical Biomimetic Therapeutics Inc
Publication of BR122020000059B1 publication Critical patent/BR122020000059B1/pt
Publication of BR122020000059B8 publication Critical patent/BR122020000059B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Neurology (AREA)
  • Composite Materials (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)

Abstract

a presente invenção refere-se a composições e métodos para o tratamento de lesões de tendão e ligamento e/ou para o reparo de tendões e ligamentos danificados. a invenção refere-se a composições que compreendem uma matriz biocompatível e um fator de crescimento derivado de plaqueta (pdgf).
BR122020000059A 2008-09-09 2009-09-09 composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit BR122020000059B8 (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US19164108P 2008-09-09 2008-09-09
US61/191,641 2008-09-09
US14408809P 2009-01-12 2009-01-12
US14412609P 2009-01-12 2009-01-12
US61/144,088 2009-01-12
US61/144,126 2009-01-12
BRPI0918611A BRPI0918611B8 (pt) 2008-09-09 2009-09-09 composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
PCT/US2009/056418 WO2010030714A2 (en) 2008-09-09 2009-09-09 Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries

Publications (2)

Publication Number Publication Date
BR122020000059B1 BR122020000059B1 (pt) 2020-12-15
BR122020000059B8 true BR122020000059B8 (pt) 2021-06-22

Family

ID=41343328

Family Applications (2)

Application Number Title Priority Date Filing Date
BR122020000059A BR122020000059B8 (pt) 2008-09-09 2009-09-09 composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
BRPI0918611A BRPI0918611B8 (pt) 2008-09-09 2009-09-09 composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0918611A BRPI0918611B8 (pt) 2008-09-09 2009-09-09 composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit

Country Status (13)

Country Link
US (3) US8870954B2 (pt)
EP (1) EP2341951A2 (pt)
JP (3) JP5816553B2 (pt)
KR (1) KR20110067035A (pt)
CN (1) CN102231992B (pt)
AU (4) AU2009291828C1 (pt)
BR (2) BR122020000059B8 (pt)
CA (1) CA2735885C (pt)
IL (1) IL211592A0 (pt)
MX (1) MX2011002555A (pt)
NZ (2) NZ602861A (pt)
WO (1) WO2010030714A2 (pt)
ZA (1) ZA201101405B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
CN101370531A (zh) 2005-11-17 2009-02-18 生物模拟治疗公司 采用rhPDGF-BB和生物相容性基质的颌面骨增高
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
EP3381463A1 (en) * 2006-06-30 2018-10-03 BioMimetic Therapeutics, LLC Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
AU2007333425B2 (en) 2006-11-03 2014-03-27 Biomimetic Therapeutics, Llc Compositions and methods for arthrodetic procedures
WO2008103690A2 (en) * 2007-02-20 2008-08-28 Biomimetic Therapeutics, Inc. Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
WO2009100454A1 (en) 2008-02-07 2009-08-13 Biomimetic Therapeutics, Inc. Compositions and methods for distraction osteogenesis
CN102811622A (zh) * 2010-02-22 2012-12-05 生物模拟治疗公司 用于治疗腱病的血小板衍生生长因子组合物和方法
JP5889780B2 (ja) 2010-03-02 2016-03-22 富士フイルム株式会社 細胞支持体及び骨再生材
EP2558024B1 (en) * 2010-04-12 2017-03-08 The University Of Miami Macroporous bioengineered scaffolds for cell transplantation
BR112012032169B1 (pt) 2010-06-17 2020-04-14 Univ Washington sistema para produzir uma estrutura que inclui fibras radialmente alinhadas e estrutura de fibra para reparar um espaço vazio em um tecido biológico
RU2445986C1 (ru) * 2010-11-19 2012-03-27 Федеральное государственное учреждение "Всероссийский центр глазной и пластической хирургии Федерального агентства по здравоохранению и социальному развитию" Способ лечения растяжений внесуставных связок и сухожилий
US10973622B2 (en) * 2011-04-25 2021-04-13 Arthrex, Inc. Internal brace for tissue repairs and reinforcements
WO2013062995A1 (en) * 2011-10-25 2013-05-02 Biomimetic Therapeutics, Inc. Compositions and methods for treating deep partial and full thickness wounds and injuries
JP6188578B2 (ja) * 2012-02-01 2017-08-30 株式会社オーガンテクノロジーズ 歯科用インプラントおよびその製造方法
CN102846671B (zh) * 2012-07-05 2014-12-17 渤海造船厂集团有限公司 一种中药制剂的制备方法
EP2897561B1 (en) 2012-09-21 2020-11-04 Washington University Biomedical patches with spatially arranged fibers
US9421221B2 (en) * 2012-11-12 2016-08-23 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting adhesion formation
US9474767B2 (en) * 2012-11-12 2016-10-25 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting bone growth
US9770415B2 (en) 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
BR112017007645B1 (pt) 2014-10-14 2023-05-02 Samuel Lynch Composições para tratar feridas
US9924962B2 (en) 2015-10-08 2018-03-27 Olympus Corporation Elbow joint surgical treatment
US10052118B2 (en) 2015-10-08 2018-08-21 Olympus Corporation Knee joint surgical treatment
US10028755B2 (en) 2015-10-08 2018-07-24 Olympus Corporation Knee joint surgical treatment
US10383642B2 (en) 2015-10-08 2019-08-20 Olympus Corporation Surgical procedure of knee joint
US10080577B2 (en) 2015-10-08 2018-09-25 Olympus Corporation Joint surgical treatment
US10052117B2 (en) 2015-10-08 2018-08-21 Olympus Corporation Joint surgical treatment
US10052119B2 (en) 2015-10-08 2018-08-21 Olympus Corporation Knee joint surgical treatment
EP3423121B1 (en) * 2016-02-29 2022-11-02 Cedars-Sinai Medical Center Endogenous stem cell activation for tendon/ligament osseointegration
CN105833359A (zh) * 2016-05-10 2016-08-10 武汉理工大学 含生长因子的肌腱吻合器的制备方法
BR112018073290B1 (pt) * 2016-05-12 2022-03-03 Acera Surgical, Inc. Material de enxerto não tecido reabsorvível
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US20180116784A1 (en) 2016-10-28 2018-05-03 Olympus Corporation Surgical procedure of knee joint
US10568733B2 (en) 2017-01-24 2020-02-25 Arthrex, Inc. Anterior cable region superior capsule reconstructions
DK3678714T3 (da) * 2017-09-04 2023-05-01 Univ Zuerich Vævsmanipuleret medicinsk indretning
EP3756698A3 (en) 2019-06-28 2021-01-06 Vivostat A/S A tissue sealant for use in anterior cruciate ligament (acl) reconstruction
CN111346262B (zh) * 2020-03-17 2022-02-01 四川大学 一种用于促进腱骨愈合的可注射钙磷陶瓷及其制备方法与应用
US11850143B2 (en) * 2020-04-30 2023-12-26 Industrial Technology Research Institute Tissue repair device and method for using the same

Family Cites Families (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943072A (en) * 1971-12-15 1976-03-09 United Kingdom Atomic Energy Authority Separation of molecules
USRE33161E (en) * 1982-04-29 1990-02-06 American Dental Association Health Foundation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
NL8402158A (nl) 1983-07-09 1985-02-01 Sumitomo Cement Co Poreus keramisch materiaal en werkwijze voor de bereiding daarvan.
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US5187263A (en) * 1984-10-12 1993-02-16 Zymogenetics, Inc. Expression of biologically active PDGE analogs in eucaryotic cells
US4849407A (en) * 1986-08-13 1989-07-18 Zymogenetics, Inc. Biologically active mosaic proteins
US5165938A (en) 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5629191A (en) * 1985-01-03 1997-05-13 Integra Lifesciences Corporation Method of making a porous matrix particle
US5516896A (en) * 1985-02-25 1996-05-14 Zymogenetics, Inc. Biologically active B-chain homodimers
US5045633A (en) 1985-02-25 1991-09-03 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US5187076A (en) * 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5108922A (en) * 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US5106748A (en) * 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
AU600069B2 (en) 1986-11-14 1990-08-02 Institute Of Molecular Biology, Inc. Wound healing and bone regeneration
US5019559A (en) * 1986-11-14 1991-05-28 President And Fellows Of Harvard College Wound healing using PDGF and IGF-II
US4861757A (en) 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
US5219759A (en) * 1987-04-22 1993-06-15 Chiron Corporation Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors
US5457093A (en) 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
US4874746A (en) 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
US5759815A (en) * 1988-02-11 1998-06-02 Creative Biomolecules, Inc. Production of platelet derived growth factor (PDGF) an muteins thereof
US4975526A (en) 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5962028A (en) 1988-04-20 1999-10-05 Norian Corporation Carbonated hydroxyapatite compositions and uses
US5129905A (en) * 1988-04-20 1992-07-14 Norian Corporation Methods for in situ prepared calcium phosphate minerals
US5053212A (en) 1988-04-20 1991-10-01 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
US5219576A (en) * 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US5034375A (en) * 1988-08-10 1991-07-23 Institute Of Molecular Biology, Inc. Process of wound healing using PDGF and EGF
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
US5112354A (en) * 1989-11-16 1992-05-12 Northwestern University Bone allograft material and method
US5011910A (en) * 1989-12-28 1991-04-30 Washington University Reagent and method for determining activity of retroviral protease
US5071655A (en) 1990-01-12 1991-12-10 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
WO1991011515A2 (en) 1990-02-01 1991-08-08 University Of South Florida Leukocyte-derived growth factor
TW199858B (pt) * 1990-03-30 1993-02-11 Fujirebio Kk
EP0479799B1 (en) 1990-04-10 1997-08-06 Institute Of Molecular Biology Inc. Wound healing
EP0536186B1 (en) 1990-05-16 2001-11-21 Genetics Institute, Inc. Bone and cartilage inductive proteins
CA2097063C (en) 1990-11-27 2006-08-08 Howard P. Greisler Tissue sealant and growth factor containing compositions that promote accelerated wound healing
US5853746A (en) 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
US5149691A (en) 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
AU654574B2 (en) * 1991-06-14 1994-11-10 Amgen, Inc. Collagen film drug delivery for proteins
WO1993000432A1 (en) 1991-06-25 1993-01-07 Genetics Institute, Inc. Bmp-9 compositions
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
KR100259827B1 (ko) 1991-11-04 2000-06-15 브루스 엠. 에이센, 토마스 제이 데스로저 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
AU3062392A (en) 1991-11-04 1993-06-07 Novo Nordisk A/S Pdgf gel formulation
PT625989E (pt) 1992-02-12 2000-06-30 Bioph Biotech Entw Pharm Gmbh Sequencias de adn que codificam novos factores de crescimento/diferenciacao
WO1993020859A1 (en) 1992-04-20 1993-10-28 Board Of Regents Of The University Of Washington Sustained release compositions for delivery of growth factors
IL106278A0 (en) 1992-07-13 1993-11-15 Sumitomo Metal Ind Bone formation-inducing protein
ES2149823T3 (es) 1992-09-03 2000-11-16 Univ California Factor y composiciones que afectan al tejido dorsal.
WO1994015965A1 (en) 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-3
WO1994015949A1 (en) 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-5
JP3482207B2 (ja) 1993-01-12 2003-12-22 ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子−９
EP1333035A3 (en) 1993-03-19 2004-07-07 The Johns Hopkins University School Of Medicine Growth differentiation factor-8
ATE180674T1 (de) 1993-03-29 1999-06-15 Zymogenetics Inc Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten
KR100231640B1 (ko) 1993-05-12 1999-12-01 토마스 제이 데스로저 Bmp-10 조성물
EP1378572B1 (en) 1993-05-12 2006-10-25 Genetics Institute, LLC Bmp-11 compositions
WO1994028889A1 (en) 1993-06-08 1994-12-22 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
WO1995001802A1 (en) 1993-07-09 1995-01-19 The Johns Hopkins University School Of Medicine Growth differentiation factor-7
JPH09503903A (ja) 1993-07-09 1997-04-22 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子−６
US5531794A (en) * 1993-09-13 1996-07-02 Asahi Kogaku Kogyo Kabushiki Kaisha Ceramic device providing an environment for the promotion and formation of new bone
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
JPH09505991A (ja) 1993-10-08 1997-06-17 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子‐１０
US5518680A (en) * 1993-10-18 1996-05-21 Massachusetts Institute Of Technology Tissue regeneration matrices by solid free form fabrication techniques
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
JP3362267B2 (ja) 1993-12-29 2003-01-07 日本特殊陶業株式会社 生体インプラント材料及びその製造方法
EP0741783B1 (en) 1993-12-30 2009-03-18 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing hedgehog-like proteins
US5460962A (en) 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
JPH07250688A (ja) 1994-01-28 1995-10-03 Sagami Chem Res Center ＴＧＦ−βスーパーファミリー蛋白質をコードするヒト新規ｃＤＮＡ
WO1995020967A1 (en) 1994-02-04 1995-08-10 Cell Therapeutics, Inc. Composition for wound healing, neuron growth and vascularization
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
AU1999995A (en) 1994-04-08 1995-11-10 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
WO1995028950A1 (en) 1994-04-20 1995-11-02 Institute Of Molecular Biology, Inc. Administration of platelet-derived growth factor and bone seeking drugs for osteoporosis and bone regeneration
US7963997B2 (en) * 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
JPH10502811A (ja) 1994-07-08 1998-03-17 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子−１１
DE69518760T2 (de) 1994-07-13 2001-05-23 The Johns Hopkins University School Of Medicine, Baltimore Wachstumsdifferenzierungsfaktor-12
US6180606B1 (en) * 1994-09-28 2001-01-30 Gensci Orthobiologics, Inc. Compositions with enhanced osteogenic potential, methods for making the same and uses thereof
US5651766A (en) 1995-06-07 1997-07-29 Transfusion Technologies Corporation Blood collection and separation system
WO1996013226A1 (en) 1994-10-31 1996-05-09 Sepracor Inc. Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method
US6281332B1 (en) 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6541037B1 (en) * 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
DE69637332T2 (de) * 1995-10-11 2008-10-09 Novartis Vaccines and Diagnostics, Inc., Emeryville Kombinierung von PDGF, KGF, IGF und IGFBP für Wundheilung
US5783217A (en) 1995-11-07 1998-07-21 Etex Corporation Low temperature calcium phosphate apatite and a method of its manufacture
US5747273A (en) * 1996-05-07 1998-05-05 Diagnostic Systems Laboratories, Inc. Immunoassay of total insulin-like growth factor binding protein-1
US6077989A (en) * 1996-05-28 2000-06-20 Kandel; Rita Resorbable implant biomaterial made of condensed calcium phosphate particles
FR2749756B1 (fr) * 1996-06-14 1998-09-11 Bioland Procede de preparation d'un materiau composite implantable, materiau obtenu, implant comprenant ce materiau et kit de mise en oeuvre
US5965403A (en) 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
US6972130B1 (en) 1996-10-16 2005-12-06 Etex Corporation Bioceramic compositions
US6037519A (en) * 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
DE19646782C2 (de) 1996-11-13 2000-05-25 Merck Patent Gmbh Bioresorbierbare Polymerisationsprodukte aus strahlungshärtbaren Bindemittelsystemen
DE69739319D1 (de) 1996-12-13 2009-04-30 Novartis Vaccines & Diagnostic Verfahren zur Expression von PDGF oder IGR Proteinen in Hefe
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
FR2758988B1 (fr) 1997-02-05 2000-01-21 S H Ind Procede d'elaboration de substituts osseux synthetiques d'architecture poreuse parfaitement maitrisee
CA2280931C (en) 1997-02-07 2009-05-05 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
DE69823955T2 (de) 1997-03-04 2005-06-16 Technology Finance Corp. (Pty.) Ltd., Sandton Als knochenimplantat geeignetes erzeugnis
US20020098222A1 (en) 1997-03-13 2002-07-25 John F. Wironen Bone paste
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
JP3334558B2 (ja) * 1997-04-23 2002-10-15 富士レビオ株式会社 酵素免疫測定方法及び試験片
US20030032586A1 (en) 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
GB2325934A (en) 1997-06-03 1998-12-09 Polybiomed Ltd Treating metal surfaces to enhance bio-compatibility and/or physical characteristics
US6063624A (en) 1997-06-09 2000-05-16 Baxter International Inc. Platelet suspensions and methods for resuspending platelets
ATE220564T1 (de) 1997-08-14 2002-08-15 Sulzer Innotec Ag Zusammensetzung und vorrichtung zur reparatur von knorpelgewebe in vivo bestehend aus nanokapseln mit osteoinduktiven und/oder chondroinduktiven faktoren
US6136029A (en) 1997-10-01 2000-10-24 Phillips-Origen Ceramic Technology, Llc Bone substitute materials
US6090998A (en) 1997-10-27 2000-07-18 University Of Florida Segmentally demineralized bone implant
JP2001517249A (ja) 1997-12-15 2001-10-02 シー ペイジ，ロイ 歯科用および整形外科用インプラント、靱帯、および腱を骨に結合させる改良方法
US20020076429A1 (en) 1998-01-28 2002-06-20 John F. Wironen Bone paste subjected to irradiative and thermal treatment
US20020018796A1 (en) * 1998-01-28 2002-02-14 John F. Wironen Thermally sterilized bone paste
JP2000004875A (ja) 1998-06-23 2000-01-11 Teijin Ltd 増殖因子の産生誘導方法
SE514908C2 (sv) 1998-07-13 2001-05-14 Gs Dev Ab Medel för benrekonstruktion
EP1100488B1 (en) 1998-07-28 2003-04-23 SYNTHES AG Chur Use of creatine compounds for treatment of bone or cartilage cells and tissues
US20030114936A1 (en) * 1998-10-12 2003-06-19 Therics, Inc. Complex three-dimensional composite scaffold resistant to delimination
US6224635B1 (en) * 1998-11-06 2001-05-01 Hospital For Joint Diseases Implantation of surgical implants with calcium sulfate
US6663870B2 (en) * 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6231528B1 (en) 1999-01-15 2001-05-15 Jonathan J. Kaufman Ultrasonic and growth factor bone-therapy: apparatus and method
EP1025871A1 (en) 1999-01-28 2000-08-09 F. Hoffmann-La Roche Ag Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
ES2209820T3 (es) * 1999-02-04 2004-07-01 Sdgi Holdings, Inc. Composiciones esponjosas osteogenicas altamente mineralizadas, y usos de las mismas.
US6294187B1 (en) 1999-02-23 2001-09-25 Osteotech, Inc. Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
ATE318625T1 (de) 1999-03-15 2006-03-15 Implant Innovations Inc Sammelsystem für thrombozyten
US6296602B1 (en) 1999-03-17 2001-10-02 Transfusion Technologies Corporation Method for collecting platelets and other blood components from whole blood
AU4173000A (en) 1999-03-19 2000-10-09 Regents Of The University Of Michigan, The Mineralization and cellular patterning on biomaterial surfaces
JP4892133B2 (ja) * 1999-04-12 2012-03-07 ハーベスト・テクノロジーズ・コーポレイション 血小板富有血漿及び／又は血小板濃縮物を製造する方法
SE515227C2 (sv) * 1999-04-28 2001-07-02 Bruce Medical Ab Kropp för åstadkommande av in- och tillväxt av benvävnad och/ eller bindväv och sätt för framställning av kroppen
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
US6710025B1 (en) * 1999-05-26 2004-03-23 The Brigham And Women's Hospital, Inc. Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
WO2000073417A1 (en) 1999-05-27 2000-12-07 The Research Foundation Of State University Of New York In vitro cell culture device including cartilage and methods of using the same
DE19926083A1 (de) 1999-06-08 2000-12-14 Universitaetsklinikum Freiburg Biologisches Gelenkkonstrukt
US20040059416A1 (en) * 1999-06-22 2004-03-25 Murray Martha M. Biologic replacement for fibrin clot
US6964685B2 (en) * 1999-06-22 2005-11-15 The Brigham And Women's Hospital, Inc. Biologic replacement for fibrin clot
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
DE19940717A1 (de) 1999-08-26 2001-03-01 Gerontocare Gmbh Resorblerbares Knochenersatz- und Knochenaufbaumaterial
US6280191B1 (en) 1999-09-03 2001-08-28 Christopher B. Gordon Distractor suitable for permanent implantation into bone
US6429748B2 (en) * 1999-09-30 2002-08-06 Nortel Networks Limited Oscillation circuits featuring coaxial resonators
AU1430601A (en) 1999-11-02 2001-05-14 Eli Lilly And Company Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
US6451059B1 (en) 1999-11-12 2002-09-17 Ethicon, Inc. Viscous suspension spinning process for producing resorbable ceramic fibers and scaffolds
AU1622801A (en) 1999-11-18 2001-05-30 Regents Of The University Of Michigan, The Sustained drug delivery from structural matrices
AU1848601A (en) 1999-12-09 2001-06-18 Bio Syntech Canada Inc Mineral-polymer hybrid composition
AU778651B2 (en) * 1999-12-16 2004-12-16 Isotis N.V. Porous ceramic body
US20030103960A1 (en) 1999-12-22 2003-06-05 Pierre Philippart Sealant and bone generating product
US20010016703A1 (en) 1999-12-29 2001-08-23 John Wironen System for reconstituting pastes and methods of using same
EP1250163B1 (de) 2000-01-28 2004-12-15 DOT GmbH Anorganisches resorbierbares knochenersatzmaterial und herstellungsverfahren
AU2000251259A1 (en) 2000-02-04 2001-08-14 Zymogenetics Inc. Methods for promoting growth of bone, ligament, and cartilage using zvegf4
IT1316769B1 (it) * 2000-02-18 2003-05-12 Getters Spa Pannello evacuato per isolamento termico con ridotta conduzione dicalore ai bordi
EP1286707A2 (en) 2000-02-18 2003-03-05 Regeneration Technologies, Inc. Implantable tissues infused with growth factors and other additives
US7022506B2 (en) * 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
JP2003525696A (ja) 2000-03-03 2003-09-02 スミス アンド ネフュー インコーポレーテッド 造形粒子および骨欠損用組成物および粒子を作る方法
US20030055511A1 (en) * 2000-03-03 2003-03-20 Schryver Jeffrey E. Shaped particle comprised of bone material and method of making the particle
ES2272452T3 (es) 2000-03-09 2007-05-01 Zimmer Orthobiologics, Inc. Producto de anclaje biologico de tejido conectivo al hueso.
WO2001068135A2 (en) 2000-03-14 2001-09-20 The University Of Western Ontario Compositions and methods for affecting osteogenesis
US20020006437A1 (en) * 2000-05-01 2002-01-17 Grooms Jamie M. Non-migration tissue capsule
US20020022885A1 (en) * 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
EP1287506A2 (en) * 2000-05-19 2003-03-05 Europrint Holdings Limited Method and system for implementing a game
US7081240B1 (en) 2000-06-28 2006-07-25 Zimmer Orthobiologics, Inc. Protein mixtures for wound healing
EP1294414B1 (en) * 2000-06-29 2006-03-15 Biosyntech Canada Inc. Composition and method for the repair and regeneration of cartilage and other tissues
DK177997B1 (da) * 2000-07-19 2015-02-23 Ed Geistlich Söhne Ag Für Chemische Ind Knoglemateriale og collagenkombination til opheling af beskadigede led
US6739112B1 (en) * 2000-08-21 2004-05-25 Nu Vasive, Inc. Bone allograft packaging system
GB0020610D0 (en) 2000-08-21 2000-10-11 Dytech Corp Ltd Uses of porous carriers
US6773723B1 (en) 2000-08-30 2004-08-10 Depuy Acromed, Inc. Collagen/polysaccharide bilayer matrix
NZ525435A (en) 2000-10-31 2004-06-25 Depuy Acromed Inc Mineralized collagen-polysaccharide matrix for bone and cartilage repair
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US20020127265A1 (en) 2000-12-21 2002-09-12 Bowman Steven M. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US7192604B2 (en) * 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
US20020193883A1 (en) 2001-01-25 2002-12-19 Wironen John F. Injectable porous bone graft materials
US7005135B2 (en) * 2001-01-30 2006-02-28 Ethicon Inc. Glass scaffolds with controlled resorption rates and methods for making same
JP2004521128A (ja) 2001-02-23 2004-07-15 ワイス Ｂｍｐによるヒト骨髄由来ｃｄ１０５＋細胞の軟骨形成能
US6743232B2 (en) 2001-02-26 2004-06-01 David W. Overaker Tissue scaffold anchor for cartilage repair
US6575986B2 (en) 2001-02-26 2003-06-10 Ethicon, Inc. Scaffold fixation device for use in articular cartilage repair
US6949251B2 (en) * 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US20030049328A1 (en) * 2001-03-02 2003-03-13 Dalal Paresh S. Porous beta-tricalcium phosphate granules and methods for producing same
US7635488B2 (en) * 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
US20040171630A1 (en) 2001-06-19 2004-09-02 Yuntae Kim Tyrosine kinase inhibitors
WO2003006025A1 (en) 2001-07-09 2003-01-23 Mayo Foundation For Medical Education And Research Methods and materials for treating bone conditions
JP2005515802A (ja) * 2001-07-16 2005-06-02 デピュイ・プロダクツ・インコーポレイテッド 混成生物／合成品型多孔質細胞外基質支持骨格
ATE359836T1 (de) 2001-09-24 2007-05-15 Millenium Biologix Inc Poröse keramische komposit-knochenimplantate
DK1446478T3 (da) 2001-10-19 2008-06-02 Zymogenetics Inc Dimeriseret vækstfaktor samt materialer og fremgangmåder til fremstilling heraf
US6649072B2 (en) 2001-11-16 2003-11-18 Robert Brandt Method for producing autologous platelet-rich plasma
AU2002365969A1 (en) 2001-11-20 2003-06-10 Scott Bruder Flowable osteogenic and chondrogenic compositions
WO2003055418A1 (en) * 2001-12-21 2003-07-10 Lagow Richard J Calcium phosphate bone replacement materials and methods of use thereof
CA2475110C (en) 2002-02-05 2010-03-23 Cambridge Scientific, Inc. Bioresorbable osteoconductive compositions for bone regeneration
EP1483298A4 (en) 2002-02-11 2007-03-14 Zymogenetics Inc MATERIALS AND METHODS FOR PREPARING DIMERED GROWTH FACTORS
WO2003070186A2 (en) 2002-02-20 2003-08-28 The Cleveland Clinic Foundation Composition and method for inducing bone growth and healing
DK175356B1 (da) 2002-02-28 2004-09-06 Coloplast As Stomiindretning
JP3739715B2 (ja) * 2002-03-19 2006-01-25 オリンパス株式会社 人工骨および組織工学用担体
KR100460685B1 (ko) 2002-04-10 2004-12-09 재단법인서울대학교산학협력재단 인산칼슘계 화합물을 이용한 인공 골 충진재 및 그 제조방법
WO2003089022A1 (en) 2002-04-18 2003-10-30 University Of Florida Biomimetic organic/inorganic composites, processes for their production, and methods of use
US7288535B2 (en) * 2002-05-02 2007-10-30 Osteoscreen, Inc. Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates
AU2003234493A1 (en) * 2002-05-06 2003-11-11 Genentech, Inc. Use of vegf for treating bone defects
AU2003235938A1 (en) * 2002-05-13 2003-11-11 Mmt.Co., Ltd Member for regenerating joint cartilage and process for producing the same, method of regenerating joint cartilage and aritficial cartilage for transplantation
US7368125B2 (en) 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7041309B2 (en) 2002-06-13 2006-05-09 Neuropro Technologies, Inc. Spinal fusion using an HMG-CoA reductase inhibitor
CA2432583A1 (en) 2002-06-20 2003-12-20 Merck Patent Gesellschaft Mit Beschraenkter Haftung Method of preparing alpha- and beta-tricalcium phosphate powders
US20040002770A1 (en) * 2002-06-28 2004-01-01 King Richard S. Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
ATE295744T1 (de) * 2002-07-11 2005-06-15 Biomet Deutschland Gmbh Verfahren zur herstellung poröser calciumphosphatstückchen und -granulaten aus der gelatineverarbeitung
US7744651B2 (en) * 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
DK1563846T3 (da) 2002-10-10 2012-12-17 Ono Pharmaceutical Co Endogene reparationsfaktorproduktionsfremmere
US7824701B2 (en) * 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
ES2269973T3 (es) 2003-02-13 2007-04-01 Synthes Ag Chur Mezcla inyectable para sustituir un tejido oseo.
ATE419812T1 (de) 2003-02-14 2009-01-15 Depuy Spine Inc In-situ hergestellte intervertebrale fusionsvorrichtung
WO2004078069A2 (en) 2003-03-05 2004-09-16 Therics, Inc. Process for manufacturing biomedical articles by infiltrating biocompatible metal alloys in porous matrices
US20040193270A1 (en) 2003-03-31 2004-09-30 Depuyacromed, Inc. Implantable bone graft
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
JP2007503292A (ja) 2003-06-11 2007-02-22 オステオテック インコーポレーテッド 骨インプラント及びその製造方法
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
ATE396669T1 (de) 2003-06-24 2008-06-15 Robert Mathys Foundation Dr H Prothesenvorrichtung zur wiederherstellung von knorpel
DE10328892A1 (de) 2003-06-26 2005-05-12 Curasan Ag Knochenaufbaumittel und Herstellungsverfahren
US7413734B2 (en) 2003-06-27 2008-08-19 Ethicon, Incorporated Treatment of retinitis pigmentosa with human umbilical cord cells
FI20031120A0 (fi) 2003-07-31 2003-07-31 Bci Bioabsorbable Concepts Ltd Monifunktionaalinen implanttilaite
US7163920B2 (en) 2003-09-30 2007-01-16 Ethicon, Inc. Peptide with osteogenic activity
CU23352A1 (es) * 2003-10-16 2009-03-16 Centro Nacional De Investigaciones Cientificas Biomateriales compuestos para implantes óseos
WO2005042048A2 (en) 2003-10-22 2005-05-12 Encelle, Inc. Bioactive hydrogel compositions for regenerating connective tissue
US20050098915A1 (en) * 2003-11-07 2005-05-12 Smith & Nephew Inc. Manufacture of bone graft substitutes
CA2536041A1 (en) 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
WO2005049132A1 (en) 2003-11-14 2005-06-02 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis and cartilage disease, defects, and injuries in the human hip
DE10355559A1 (de) 2003-11-21 2005-06-23 Orthogen Ag Transskin
EP1537839A1 (en) 2003-12-02 2005-06-08 Dr. h. c. Robert Mathys Foundation Prosthetic device for cartilage repair
AU2005209304B2 (en) 2004-01-27 2010-08-26 Warsaw Orthopedic, Inc. Stabilized bone graft
US7189263B2 (en) 2004-02-03 2007-03-13 Vita Special Purpose Corporation Biocompatible bone graft material
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US7671012B2 (en) 2004-02-10 2010-03-02 Biosurface Engineering Technologies, Inc. Formulations and methods for delivery of growth factor analogs
US7928059B2 (en) 2004-02-24 2011-04-19 Wisconsin Alumni Research Foundation Use of neuropeptides for traumatic cartilage injury
KR101013999B1 (ko) 2004-03-19 2011-02-14 재단법인서울대학교산학협력재단 표면에 골조직 형성 증진 펩타이드가 고정된 차폐막 및임플란트
US20070190101A1 (en) 2004-03-31 2007-08-16 Chunlin Yang Flowable bone grafts
WO2006031388A2 (en) 2004-08-20 2006-03-23 Hyperbranch Medical Technology, Inc. Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
WO2006034365A2 (en) 2004-09-21 2006-03-30 Massachusetts Institute Of Technology Gradient scaffolding and methods of producing the same
US7473678B2 (en) * 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US20070232455A1 (en) 2004-10-22 2007-10-04 Mytrak Health System Inc. Computerized Physical Activity System to Provide Feedback
US7250550B2 (en) 2004-10-22 2007-07-31 Wright Medical Technology, Inc. Synthetic bone substitute material
WO2006050493A2 (en) 2004-11-03 2006-05-11 The Regents Of The University Of Michigan Biodegradable implant for intertransverse process fusion
US20060149392A1 (en) 2004-12-07 2006-07-06 Kuo-Huang Hsieh Biomaterials for guided tissue regeneration and drug delivery
US20060151383A1 (en) 2005-01-12 2006-07-13 Aaf-Mcquay Inc. Pleated corrugated media and method of making
US7621963B2 (en) 2005-04-13 2009-11-24 Ebi, Llc Composite bone graft material
ES2516690T5 (es) 2005-06-07 2017-11-21 The Regents Of The University Of Colorado, A Body Corporate Inhibidores de la actividad de serina proteasa y su uso en métodos y composiciones para el tratamiento de rechazo de injertos y promoción de supervivencia de injertos
CN101370531A (zh) 2005-11-17 2009-02-18 生物模拟治疗公司 采用rhPDGF-BB和生物相容性基质的颌面骨增高
US7749555B2 (en) 2006-01-25 2010-07-06 Medtronic, Inc Modification of chemical forces of bone constructs
MX2008009665A (es) 2006-01-27 2008-10-06 Univ California Andamios biomimeticos.
US20070178159A1 (en) 2006-01-30 2007-08-02 Alza Corporation In-Situ Forming Porous Scaffold
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US7833270B2 (en) 2006-05-05 2010-11-16 Warsaw Orthopedic, Inc Implant depots to deliver growth factors to treat osteoporotic bone
AU2007250080B2 (en) 2006-05-08 2011-08-18 Nuvasive, Inc. Cancellous bone treated with collagenase and essentially free of blood cells
EP3381463A1 (en) * 2006-06-30 2018-10-03 BioMimetic Therapeutics, LLC Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
AU2007320018B2 (en) * 2006-09-28 2014-03-06 Children's Medical Center Corporation Methods and collagen products for tissue repair
US8709464B2 (en) * 2007-01-10 2014-04-29 The Regents Of The University Of Michigan Porous objects having immobilized encapsulated biomolecules
CN100556468C (zh) * 2007-05-25 2009-11-04 浙江大学 一种膜状组织工程支架及其应用
CA2690457C (en) * 2007-06-15 2018-02-20 Osteotech, Inc. Bone matrix compositions and methods
CN101130111A (zh) * 2007-09-21 2008-02-27 北京荣智高科生物科技有限公司 生物可吸收人工骨膜及其制备方法
US7993679B2 (en) * 2007-09-25 2011-08-09 Integra Lifesciences Corporation Flowable wound matrix and its preparation and use

Also Published As

Publication number Publication date
AU2009291828B2 (en) 2015-11-19
NZ602861A (en) 2014-03-28
JP2018030895A (ja) 2018-03-01
KR20110067035A (ko) 2011-06-20
US8870954B2 (en) 2014-10-28
JP5816553B2 (ja) 2015-11-18
CA2735885C (en) 2018-08-28
ZA201101405B (en) 2014-04-30
US11135341B2 (en) 2021-10-05
CN102231992A (zh) 2011-11-02
EP2341951A2 (en) 2011-07-13
CN102231992B (zh) 2015-05-20
JP2012502066A (ja) 2012-01-26
JP6577232B2 (ja) 2019-09-18
US20160184482A1 (en) 2016-06-30
IL211592A0 (en) 2011-05-31
MX2011002555A (es) 2011-08-03
US20200139013A1 (en) 2020-05-07
BRPI0918611A2 (pt) 2019-09-03
BRPI0918611B1 (pt) 2020-10-20
CA2735885A1 (en) 2010-03-18
JP2015178511A (ja) 2015-10-08
US20100174368A1 (en) 2010-07-08
AU2009291828C1 (en) 2016-03-17
BR122020000059B1 (pt) 2020-12-15
AU2017232210A1 (en) 2017-10-12
BRPI0918611B8 (pt) 2021-06-22
AU2009291828A1 (en) 2010-03-18
AU2016201014A1 (en) 2016-03-03
US10556039B2 (en) 2020-02-11
AU2019203223A1 (en) 2019-05-30
NZ591338A (en) 2013-02-22
WO2010030714A8 (en) 2011-03-10
WO2010030714A2 (en) 2010-03-18
WO2010030714A3 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
BR122020000059B8 (pt) composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
BR112022007627A2 (pt) Compostos moduladores do glp-1r
WO2008005427A3 (en) Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
BRPI0809655A2 (pt) Método para tratar uma condição em um mamífero, composição farmacêutica, e, kit
SV2010003556A (es) Moleculas y metodos para modular el componente de complemento
CY1114872T1 (el) Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης
CO6300826A2 (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
BR112023021978A2 (pt) Compostos de carbóxi-benzimidazol moduladores de glp-1r
BR112012017564A2 (pt) Formulação antimicrobiana
CR10211A (es) Compuestos de tiazol y métodos de uso
BRPI0721503A8 (pt) composições e métodos para tratamento de um poço bloqueado por água
BRPI0512903A (pt) métodos e composições para o tratamento da dor e outras condições mediadas pelo alfa 2 adrenérgico
BRPI0810130A8 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida
BRPI0908503A2 (pt) partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
DK2094325T3 (da) Fremstilling af væv til meniskimplantation
BRPI0906478B8 (pt) anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende
BRPI0918194A2 (pt) ''composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo que sofre de uma condição patológica ou doença e produto de combinação
BRPI0915979A2 (pt) Métodos para melhorar a qualidade de vida de um animal, para aumentar a qualidade de vida de um animal, para tratar um animal sofrendo de um distúrbio ou doença, para medir o aumento na qualidade de vida de um animal, e para identificar um animal que pode se beneficiar da alimentação com uma composição de ração, e, kit.
BR112013026686A2 (pt) tratamento de resíduo
BR112023021561A2 (pt) Compostos de carbóxi-benzimidazol moduladores de glp-1r
BR112012020628A2 (pt) fotoiniciador de éter polialquílico, uso de um fotoiniciador de éter polialquílico, método para curar uma composição de matriz, e, composição de matriz
BRPI0713447A2 (pt) composição forma de dosagem oral sólida, e, método para o tratamento de dor
CL2009000309A1 (es) Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2.
BR112012015960A2 (pt) Composições incluindo piruvato para animais de companhia e métodos de uso destas.
BRPI0702163A (pt) composições de toner e métodos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: REFERENTE AO DESPACHO 9.1 NA RPI 2595, DE 29/09/2020

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/09/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: EXTINCAO DA PATENTE POR FALTA DE PAGAMENTO DA RETRIBUICAO ANUAL, POR PAGAMENTO DA RETRIBUICAO ANUAL FORA DO PRAZO OU POR NAO CUMPRIMENTO DE EXIGENCIA DE COMPLEMENTACAO DE PAGAMENTO DA RETRIBUICAO ANUA

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: MANUTENCAO DA EXTINCAO - ART. 78 INCISO IV DA LPI